Asymchem Laboratories (Tianjin) Co., Ltd.

Asymchem Laboratories (Tianjin) provides contract development and manufacturing organization (CDMO) solutions in Mainland China and globally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes. Its portfolio also includes chemical macromolecule CDMO, biomacromolecule CDMO, including antibody-peptide conjugates, formulation CDMO, clinical CRO, and synthetic biology and new technology output business Key pharmaceutical intermediates, APIs, and formulations activities. Founded in 1998, the company is headquartered in Tianjin, China.